Search Results

Recent development of acupuncture on Parkinson's disease

Authors: Joh, Tong H.; Park, Hi-Joon; Kim, Seung-Nam; Lee, Hyejung

Source: Neurological Research, Volume 32, Supplement 1, February 2010 , pp. 5-9(5)

Publisher: Maney Publishing

Sulforaphane as an inducer of glutathione prevents oxidative stress-induced cell death in a dopaminergic-like neuroblastoma cell line

Authors: Tarozzi, Andrea; Morroni, Fabiana; Merlicco, Adriana; Hrelia, Silvana; Angeloni, Cristina; Cantelli-Forti, Giorgio; Hrelia, Patrizia

Source: Journal of Neurochemistry, Volume 111, Number 5, December 2009 , pp. 1161-1171(11)

Publisher: Blackwell Publishing

Cannabinoids and Neurodegenerative Diseases

Authors: Romero, Julian; Martinez-Orgado, Jose

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 8, Number 6, December 2009 , pp. 440-450(11)

Publisher: Bentham Science Publishers

Established therapies and novel targets in the treatment of Parkinson's disease

Authors: Dézsi, Livia; Vécsei, László

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 631-644(14)

Publisher: Expert Reviews

Pharmacomimetics of Exercise: Novel Approaches for Hippocampally- Targeted Neuroprotective Agents

Authors: Stranahan, A. M.; Zhou, Y.; Martin, B.; Maudsley, S.

Source: Current Medicinal Chemistry, Volume 16, Number 35, December 2009 , pp. 4668-4678(11)

Publisher: Bentham Science Publishers

Natural Coumarins as a Novel Class of Neuroprotective Agents

Authors: Epifano, Francesco; Curini, Massimo; Menghini, Luigi; Genovese, Salvatore

Source: Mini Reviews in Medicinal Chemistry, Volume 9, Number 11, October 2009 , pp. 1262-1271(10)

Publisher: Bentham Science Publishers

NO-flurbiprofen reduces amyloid-β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade

Authors: Abdul-Hay, Samer O.; Luo, Jia; Ashghodom, Rezene T.; Thatcher, Gregory R. J.

Source: Journal of Neurochemistry, Volume 111, Number 3, November 2009 , pp. 766-776(11)

Publisher: Blackwell Publishing

Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure- Activity Relationships of a Neuroprotective Peptide

Authors: Bourgault, S.; Vaudry, D.; Dejda, A.; Doan, N. D.; Vaudry, H.; Fournier, A.

Source: Current Medicinal Chemistry, Volume 16, Number 33, November 2009 , pp. 4462-4480(19)

Publisher: Bentham Science Publishers

Guillain-Barré syndrome: update on immunobiology and treatment

Authors: Kaida, Kenichi; Kusunoki, Susumu

Source: Expert Review of Neurotherapeutics, Volume 9, Number 9, September 2009 , pp. 1307-1319(13)

Publisher: Expert Reviews

Antioxidative and Anti-Inflammatory Neuroprotective Effects of Astaxanthin and Canthaxanthin in Nerve Growth Factor Differentiated PC12 Cells

Authors: Chan, Kung-chi; Mong, Mei-chin; Yin, Mei-chin

Source: Journal of Food Science, Volume 74, Number 7, September 2009 , pp. H225-H231(1)

Publisher: Blackwell Publishing

Beta-blockers in the Perioperative Period: Are there Indications other than Prevention of Cardiac Ischemia?

Authors: Kadoi, Y.; Saito, S.

Source: Current Drug Targets, Volume 10, Number 9, September 2009 , pp. 842-849(8)

Publisher: Bentham Science Publishers

Peri-operative medical management of cerebral vasospasm

Authors: Deshaies, Eric Michael; Boulos, Alan S.; Popp, A. John

Source: Neurological Research, Volume 31, Number 6, July 2009 , pp. 644-650(7)

Publisher: Maney Publishing

Protective effect of ginsenoside Rb1 on β-amyloid protein(1-42)-induced neurotoxicity in cortical neurons

Authors: Qian, Yi-Hua; Han, Hua; Hu, Xiao-Dan; Shi, Li-Li

Source: Neurological Research, Volume 31, Number 7, September 2009 , pp. 663-667(5)

Publisher: Maney Publishing

Pharmacotherapy of cerebral ischemia

Authors: Ducruet, Andrew F; Grobelny, Bartosz T; Zacharia, Brad E; Hickman, Zachary L; Yeh, Mason L; Connolly, E Sander

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 12, August 2009 , pp. 1895-1906(12)

Publisher: Informa Healthcare

Metabotropic Glutamate Receptors in the Control of Neuronal Activity and as Targets for Development of Anti-Epileptogenic Drugs

Authors: Tang, Feng R.; Bradford, Henry F.; Ling, Eng-Ang

Source: Current Medicinal Chemistry, Volume 16, Number 17, June 2009 , pp. 2189-2204(16)

Publisher: Bentham Science Publishers

Estrogens as Potential Therapeutic Agents in Multiple Sclerosis

Authors: Niino, Masaaki; Hirotani, Makoto; Fukazawa, Toshiyuki; Kikuchi, Seiji; Sasaki, Hidenao

Source: Central Nervous System Agents in Medicinal Chemistry(Formerly Current Medicinal, Volume 9, Number 2, June 2009 , pp. 87-94(8)

Publisher: Bentham Science Publishers

Clinical application of therapeutic hypothermia in stroke

Authors: Liu, Liping; Yenari, Midori A.

Source: Neurological Research, Volume 31, Number 4, May 2009 , pp. 331-335(5)

Publisher: Maney Publishing

Olanzapine Does not Aggrevate Ischemic Neuronal Injury by Focal Cerebral Ischemia: A Dose Related Restriction of the Neuroprotective Effect?

Authors: Yulug, Burak; Kilic, Ertugrul

Source: Medicinal Chemistry, Volume 5, Number 3, May 2009 , pp. 279-282(4)

Publisher: Bentham Science Publishers

Combination therapy with Coenzyme Q₁₀ and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's Diseases

Authors: Yang, Lichuan; Calingasan, Noel Y.; Wille, Elizabeth J.; Cormier, Kerry; Smith, Karen; Ferrante, Robert J.; Flint Beal, M.

Source: Journal of Neurochemistry, Volume 109, Number 5, June 2009 , pp. 1427-1439(13)

Publisher: Blackwell Publishing

Neuroinflammation and Neuroprotective Strategies in Acute Ischaemic Stroke - from bench to bedside

Authors: Shah, Imtiaz M.; Macrae, I. M.; Di Napoli, Mario

Source: Current Molecular Medicine, Volume 9, Number 3, April 2009 , pp. 336-354(19)

Publisher: Bentham Science Publishers